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Uses of different D-dimer levels can reduce the
need for venous duplex scanning to rule out deep
vein thrombosis in patients with symptomatic
pulmonary embolism
Takashi Yamaki, MD, Motohiro Nozaki, MD, Hiroyuki Sakurai, MD, Masaki Takeuchi, MD,
Kazutaka Soejima, MD, and Taro Kono, MD, Tokyo, Japan
Objective: This study investigated the prevalence and distribution of deep vein thrombosis (DVT) in patients with
symptomatic pulmonary embolism (PE) to establish a screening protocol to reduce unnecessary venous duplex scanning
using different D-dimer level rather than single cutoff point of 0.5 g/mL in patients with low and moderate pretest
clinical probability (PTP).
Methods: The PTP score and D-dimer testing were used to evaluate 85 consecutive patients with symptomatically proven
PE before venous duplex scanning. After calculating the PTP score, patients were divided into low (<0 points), moderate
(1 to 2 points), and high (>3 points) PTP groups. The receiver operating characteristic (ROC) curves analysis was used
to determine the appropriate D-dimer cutoff point in low and moderate PTP, with a negative predictive value of >98%.
Results: The study enrolled 81 patients. The prevalence of DVT was 63%, with 27 patients (33%) classified as low, 38
(47%) as moderate, and 16 (20%) as high PTP. DVT was detected in nine patients (33%) in the low PTP group, in 27
(71%) in the moderate group, and in 15 (94%) in the high group. In the low PTP patients, the difference in the value of
D-dimer assay between positive-scan and negative-scan patients was statistically significant (9.99  7.33 vs 3.46  4.20,
respectively; P  .008). Conversely, no significant difference in the D-dimer assay value between positive and negative
scan results was found in the moderate PTP patients. ROC curves analysis were used to select D-dimer cutoff points of
2.0 g/mL for the low PTP group and 0.7 g/mL for the moderate PTP groups. For both groups, D-dimer testing
provided 100% sensitivity and 100% negative predictive value in the diagnosis of DVT. In the low PTP group, specificity
increased from 33% to 67% (P  .046). In the moderate PTP group, however, the determined D-dimer level did not
improve the specificity. Overall, venous duplex scanning could have been reduced by 17% (14/81) by using different
D-dimer cutoff points.
Conclusions:A combination of specific D-dimer level and clinical probability score is most effective in the low PTP patients
in excluding DVT. In the moderate PTP group, however, the recommended cutoff point of 0.5 g/mL may be
preferable. These results show that a different D-dimer level is more useful than single cutoff point of 0.5 g/mL in
excluding DVT in established PE patients. ( J Vasc Surg 2007;46:526-32.)Accurate diagnosis of venous thromboembolism (VTE)
still remains a difficult challenge for clinicians. Clinical signs
and symptoms are inaccurate, and an accurate diagnostic test
is mandatory to exclude VTE. In addition, pulmonary embo-
lism (PE) is a common and potentially life-threatening occur-
rence. Because 80% of PE arise from lower extremity veins, 1
diagnosis and treatment of deep vein thrombosis (DVT) is
of primary importance. Although contrast venography and
pulmonary angiography remain the gold standard for the
diagnosis of VTE, these studies have largely been replaced
by noninvasive venous duplex scanning (VDS) and spiral
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526computed tomography (CT) scanning. VDS has been
shown to be a reliable and accurate means of identifying
lower extremity VTE. As a consequence, it has been heavily
used inDVT detection because it is noninvasive and neither
iodinated contrast media nor ionizing radiation is used.
The clinical pretest probability (PTP) score is a useful
tool for selecting patients for further diagnostic examina-
tion for DVT. The PTP score developed by Well et al2 is
calculated from clinical and historical data to stratify pa-
tients into low, moderate, and high risk of DVT.2 They
found that the difference in the prevalence of DVT in the
three categories was statistically significant and concluded
that a combination of patients’ PTP with ultrasound imag-
ing results had the potential to simplify and improve the
diagnostic process in patients with suspected DVT.
The D-dimer assay is another useful test to select pa-
tients who require further diagnostic evaluation for DVT.
The D-dimer assay has a very high sensitivity and can safely
exclude the diagnosis of VTE without the need for further
investigations. Very sensitive D-dimer assays have low spec-
ificity for VTE, however, which results in a high frequency
of false-positive VDS results.3 Furthermore, although the
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exclude the diagnosis of DVT in patients without PE,4-19
there is no evidence supporting this strategy for patients
with established diagnosis of acute PE.
The purpose of this study was to investigate the preva-
lence and distribution of DVT in patients with symptom-
atic PE and to establish a screening protocol to reduce
unnecessary VDS by using different D-dimer levels rather
than a single cutoff point of 0.5 g/mL in patients with
low and moderate PTP.
MATERIALS AND METHODS
Patients. From February 2004 to October 2006, 85
consecutive referral patients with confirmed cardiopulmo-
nary stable PE were prospectively evaluated with lower
extremity VDS for the detection of DVT in theDepartment
of Plastic and Reconstructive Surgery, Tokyo Women’s
Medical University Hospital. The management of all pa-
tients with proven PE was performed in the pulmonary or
cardiovascular unit. Exclusion criteria from the study in-
cluded (1) previously diagnosed DVT, (2) features of
chronic DVT on duplex scan results, (3) lower extremity
symptoms lasting 1 month, (4) cardiopulmonary unstable
PE with massive PE, and (5) therapeutic dose anticoagula-
tion instituted for 48 hours before examination.17 This
study was approved by the Institutional Review Board, and
informed consent was obtained from all participants.
Clinical probability score. The PTP for DVT was
assessed at the time of referral by using a questionnaire
developed by Wells et al.2 One point was added for each
positive finding, and 2 points were subtracted from the
total points if an alternative diagnosis as likely as or more
likely than DVT was found. After the PTP scores were
calculated, patients were stratified into low-risk (0
points), moderate-risk (1 to 2 points), and high-risk (3
points) groups.
D-dimer assay. D-dimer concentration was measured
using a commercially available enzyme immunoassay (EIA)
kit (D-dimer test-F; Kokusai-Shiyaku, Kobe, Japan). All
D-dimer assays were measured by technologists who were
not aware of clinical feature of the patients.
Briefly, D-dimers are bound to murine antihuman
D-dimmer monoclonal antibodies fixed on the surface of
the test tube. After incubation and washing, an excess of
polyclonal rabbit anti–D-dimer coupled with peroxidase
was added to the test tubes and bound to the fixed D-
dimer/anti–D-dimer complex. After washing the excess
enzyme conjugated antibody, the amount of D-dimer fixed
to the tube was quantified by adding a substrate that
converts to a colored substance using peroxidase. The
manufacture’s recommended cutoff value for a positive test
was 0.5 g/mL.
Venous duplex scans. All VDSs were performed by
one experienced physician (T. Y.) who was blinded to the
results of PTP and D-dimer testing. A color duplex scanner
(LOGIQ 500MD: GEMedical Systems, Milwaukee, Wisc)
with a 5 to 10 MHz transducer was used. Each patient was
initially placed supine in a reverse Trendelenburg positionat 15°. The VDSs began at the distal segment of the
external iliac vein and the common femoral vein andmoved
to the femoral vein at the adductor canal. The deep femoral
vein and the anterior and posterior tibial veins were also
recorded. Afterwards the patient was placed in a prone
position with the knee flexed at 30°, and the residual
popliteal, peroneal, gastrocnemius, and soleal veins were
evaluated.20
The diagnosis of DVT was based on both noncom-
pressibility of the vein on B-mode and no spontaneous flow
on color Doppler imaging. If there was no intraluminal
defect with a full venous compressibility and a normal flow,
the examination result was considered as negative. Throm-
bosis was considered proximal if it involved the deep veins
in the pelvis, the thigh, and popliteal region, with or
without calf vein thrombosis. Thrombosis was considered
distal if it involved only the calf veins.
Statistical analysis. All data were analyzed using
StatView 5.0 software (SAS Institute Inc. Cary, NC). The
Wilcoxon nonparametric rank sum test was used to evaluate
differences between means for continuous data, and a 2
test was used to evaluate differences between proportions.
The analysis of variance was used for comparison of D-
dimer assay means among high, moderate, and low PTP
groups. The receiver operating characteristic (ROC) curves
analysis (MedCalc software, Mariakerke, Belgium) was
used to determine appropriate D-dimer cutoff point for a
positive VDS in the low and moderate PTP groups, with a
negative predictive value of 98%. Continuous data were
expressed as mean  standard deviation. Statistical signifi-
cance was defined as P  .05.
RESULTS
Table I summarizes the baseline characteristics of the
Table I. Baseline characteristics of the study patients
Parameters Data
Characteristics
Number of patients eligible 81
Number of patients with DVT 51 (63.0%)
Mean age (y) 63.1  15.7
Male gender, n (%) 34 (42.0%)
Risk factors
Operation and trauma 33 (40.7%)
Immobilization 19 (23.5%)
Active cancer 13 (16.0%)
Congestive heart disease 11 (13.6%)
Hormone replacement therapy 10 (12.3%)
Renal failure 7 (8.6%)
Previous history of DVT 6 (7.4%)
Stroke 2 (2.4%)
Long travel 2 (2.4%)
Inflammatory bowel disease 1 (1.2%)
Pregnancy 1 (1.2%)study patients. Four of the 85 consecutive patients evalu-
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described. Thus, 81 patients, 47 women (58%) and 34 men
(42%) with a mean age of 63 years (range, 24 to 95), were
eligible for this study. DVTwas present in 51 (63%), and 33
(65%) had leg symptoms. An operation or trauma was the
most common risk factor for DVT, found in 33 (41%),
followed by immobilization in 19 (24%), active cancer in 13
(16%), and congestive heart disease in 11 (14%).
At the initial examination, 25 patients (49%) had prox-
imal DVT, and the remaining 26 (51%) had distal DVT
(Table II). No significant difference was found in the
proportion of DVT (P .843) in each location. There were
21 patients (41%) with an isolated venous segment DVT,
and the remaining 30 (59%) had multisegment DVT. In
the isolated venous segment, distal veins had a significantly
higher proportion of DVT compared with proximal veins
(P  .0001). Conversely, a significantly higher proportion
of DVT with multisegment DVT extended from the prox-
imal to distal veins (P  .0001). Fig 1 shows the detailed
anatomic distribution of DVT. Clot burden segment was
most frequently found in the soleal veins (67%), followed
by the peroneal (35%), popliteal (31%), common femoral
(28%), and femoral veins (27%). In contrast, thrombi were
less frequently found in the anterior (4%) and posterior
Table II. Distribution of deep vein thrombosis
DVT distribution Segments, n (%) P*
Proximal DVT 25 (49.0)
Distal DVT 26 (51.0) .843
Total 51 (100)
Isolated segment
Proximal DVT 2 (3.9)
Distal DVT 19 (37.3) .0001
Total 21 (41.2)
Multisegment
Proximal DVT 23 (45.1)
Distal DVT 7 (13.7) .0001
Total 30 (58.8)
DVT, Deep vein thrombosis.
*Pearson 2 test.
Fig 1. Detailed anatomic distribution of deep vein thrombosis.
EIV, External iliac vein; CFV, common femoral vein; FV, femoral
vein;DFV, deep femoral vein; POPV, popliteal vein;ATV, anterior
tibial vein; PTV, posterior tibial vein; PV, peroneal vein; GV,
gastrocnemius vein; SV, soleal vein.tibial veins (6%).Table III lists the distribution of the patients with low,
moderate, and high risk according to the calculated PTP
score. Of 81 patients, 27 (33%) were classified as low, 38
(47%) as moderate, and 16 (20%) as high risk by PTP. DVT
was found in nine patients (33%) in the low-risk group. In
contrast, DVTwas found in 27moderate-risk (71%) and 15
high-risk patients (94%). Prevalence of DVT increased as
the risk for DVT assessed by PTP score progressed. The
results of the D-dimer assay showed no statistically signifi-
cant differences between the PTP risk groups.
Table IV shows the results of the D-dimer assay. In the
moderate PTP patients, there was no significant difference
in the D-dimer assay value between patients with positive
and negative DVT scan results. In the low PTP patients,
however, the difference in the value of the D-dimer assay
between positive and negative scan patients was statistically
significant (9.99  7.33 vs 3.46  4.20, respectively; P 
.008).
The discriminating power of the D-dimer cutoff point
of 0.5 g/mL for low and moderate, and high PTP
patients, and entire study population, is summarized in
Table V. In all groups, D-dimer testing achieved 100%
sensitivity and negative predictive value (NPV) in the diag-
nosis of DVT; however, as the PTP score increased from
low to moderate and to high, the specificity decreased from
33% to 18% to 0%. To improve the discrimination power of
D-dimer assay, ROC curve analysis was used to determine
different cutoff points in the low andmoderate PTP groups
(Fig 2 and Fig 3). D-dimer cutoff points of 2.0 and
Table III. Prevalence of deep vein thrombosis by pretest
clinical probability risk classification
Pretest clinical
probability N (%)
DVT frequency,
n (%) D-dimer (g/mL)*
High risk 16 (19.8) 15 (93.8) 11.36  14.20
Moderate risk 38 (46.9) 27 (71.1) 8.51  10.77
Low risk 27 (33.3) 9 (33.3) 5.64  6.16
Total 81 (100) 51 (63.0)
DVT, Deep vein thrombosis.
Continuous values are expressed as mean  standard deviation.
*The analysis of variance was used for for multiple comparison.
Table IV. Results of D-dimer assay between patients
with positive and negative scans
D-dimer
(g/mL)
Venous duplex scanning
P*
Positive Negative
No. Value No. Value
High PTP 15 11.76  14.61 1 5.31 NS
Moderate PTP 27 10.69  11.99 11 3.14  3.35 .051
Low PTP 9 9.99  7.33 18 3.46  4.20 .008
PTP, Pretest clinical probability.
Values are expressed as mean  standard deviation.
*Wilcoxon’s nonparametric rank sum test.0.7 g/mL were selected for the low and moderate PTP
clinic
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dimer testing still provided 100% sensitivity and 100%
negative predictive value in the diagnosis of DVT for both
groups (Table VI). However, using these specific cutoff
points in the low PTP patients increased the specificity from
33% to 67% (P  .046), whereas in the moderate PTP
group, the newly determined D-dimer level did not im-
prove the specificity.
Finally, with the use of the single D-dimer cutoff point
of 0.5 g/mL, eight of 81 patients with a low or a moder-
ate PTP score and a normal D-dimer assay required no
further investigation, and thus VDS could be reduced by
10% (8/81). However, by using the specificD-dimer cutoff
points for the various PTP groups, six additional patients
could have been excluded compared with recommended
cutoff level of 0.5 g/mL, and thus VDSs could have been
reduced by 17% (14/81).
DISCUSSION
A combination of a PTP score and D-dimer testing has
previously been considered validated as a diagnostic strat-
Table V. The discriminating power of D-dimer testing of
clinical probability category
Patient group Sensitivity (%) Sp
All patients 51/51 (100) 8/
High PTP 15/15 (100) 0
Moderate PTP 27/27 (100) 2/
Low PTP 9/9 (100) 6/
PPV, Positive predictive value; NPV, negative predictive value; PTP, pretest
Fig 2. Receiver operating characteristics curves analysis for low
pretest probability (PTP).egy for PE or DVT exclusion,4-19 and this strategy isspecifically validated for patients who have low PTP.
Anderson et al5 showed that the observed NPV of the
D-dimer assay was 100% in the low-probability patients,
94.1% in moderate-probability patients, and 86.7% in high-
probability patients. They concluded that the D-dimer
assaymight be a potentially useful adjunctive test to exclude
the diagnosis of DVT in patients with PTP scores. Further-
more, Schutgens et al13 showed that DVT could be ex-
cluded in patients with a normal D-dimer concentration
and a low and moderate PTP score. They also demon-
strated that anticoagulation can be safely withheld in pa-
tients with suspected DVT when the combination of a low
PTP score and a normal D-dimer concentration is present.
Finally, Yamaki et al8 found among each PTP group that
D-dimer testing provided 100% sensitivity and 100% NPV
in the diagnosis of DVT.
Using D-dimer testing and PTP for exclusion of VTE
depends largely on the reliability of the D-dimer test.
Several methods are commercially available for measuring
D-dimer concentrations. Despite laboratory-based and rel-
atively time-consuming examinations, techniques based on
gle D-dimer cutoff point of 0.5 g/mL by pretest
ty (%) PPV (%) NPV (%)
26.7) 51/73 (69.9) 8/8 (100)
0) 15/16 (93.8) 0/0 (NA)
18.2) 27/36 (75.0) 2/2 (100)
33.3) 9/21 (42.9) 6/6 (100)
al probability; NA, not applicable.
Fig 3. Receiver operating characteristics curves analysis for mod-
erate pretest probability (PTP).a sin
ecifici
30 (
/1 (
11 (
18 (EIA or enzyme linked immunosorbent assays (ELISA) are
clinic
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D-dimer, with the highest sensitivity and NPV for DVT.7,8
The latex agglutination assay had relatively low sensitivity
and specificity for DVT in the past7; however, early latex
assays have been replaced by newer assays with improved
sensitivity and NPV.12,13
Schutgens et al14 evaluated four new D-dimer assays
and a classic ELISA in outpatients with symptoms suggestive
of DVT and concluded that the Tina-quant latex assay
(Roche, Mannheim, Germany) had the highest NPV of 98%,
and a high sensitivity of 99% using the standard cutoff value.14
Recent studies have also shown that a rapid method of D-
dimer assay on the basis of whole blood agglutination that
could be performed at the bedside is useful in excluding
patients without DVT.4-6,15-18 Wells et al15 evaluated 214
patients with clinically symptoms suggestive ofDVTusing the
SimpliRED D-dimer assay (AGEN Biomedical, Brisbane,
Australia), which had a sensitivity of 93% for proximal DVT
and a negative predictive value of 98%. Di Nisio et al18 studied
the combined use of PTP and D-dimer assay and found that
D-dimer testing achieved a NPV of 100% and 97% among
cancer patients with low PTP or low-moderate PTP scores,
whereas corresponding NPV in the absent of malignancy was
98% and 97%, respectively.
Another factor that could affect the discriminating
power of the studies for VTE is the cutoff value of the
D-dimer test. The sensitivity could be improved by lower-
ing the cutoff value, but the subsequent decrease in speci-
ficity would lead to a large number of false-positive results.
D-dimer cutoff values with very high specificity provide
fewer false-positive results, but they are less sensitive for
VTE and cannot be used to exclude the disease in all
patients.
Against this background, Linkins et al19 used data from a
previously published study of 571 patients and reported that
varying the D-dimer cutoff values according to PTP score
would exclude VTE in more patients than using the single
D-dimer cutoff point.19 In that analysis, they found in the
high PTP score group that a D-dimer cutoff of 0.2 g fibrin-
ogen equivalent units (FEU)/mL was required to achieve a
NPV of 98% or higher. Similarly, in the low PTP score group,
aD-dimer cutoff point of 2.1gFEU/mLachieved aNPVof
98% or higher. With this strategy, the number patients with
false-positive results also dropped from 89 to nine in the low
PTP group (n 205).
Patients with PE usually present with an elevated
D-dimer assay, and D-dimer values 0.5 g/mL have an
Table VI. Sensitivity, specificity, and positive and negative
Patient group Cutoff point (g/mL) Sensitivity (
All patients 2.0/0.7/0.5 51/51 (10
High PTP 0.5 15/15 (10
Moderate PTP 0.7 27/27 (10
Low PTP 2.0 9/9 (10
PPV, Positive predictive value; NPV, negative predictive value; PTP, pretestalmost 100% NPV for DVT exclusion.21,22 Moreover, Per-rier et al22 found that a D-dimer level 4 g/mL was
associated with a specificity of 93% for PE detection.22
Later, Kucher et al23 studied 85 PE-positive patients and
found that the D-dimer level should be 7 g/mL to
achieve the specificity of 100%.23 In the current study,
however, the D-dimer value in patients with no DVT was
much lower than 7 g/mL. The possible explanation for
this is that only cardiopulmonary stable PE patients were
selected for this study. Even patients with small PE were
referred to our department. Elevated D-dimer levels are
present in many other circumstances, however, including
advanced age24 and during postoperative periods.25 There-
fore, a decision-making positive diagnosis threshold cannot
be defined with D-dimmer alone.12
The presence of proximal DVT is considered to be a
part of PE diagnosis.12 In contrast, the screening for DVT
in patients with proven or suspected symptomatic PE still
remains debated.26,27 Giachino et al26 reported that 13% of
fatal pulmonary emboli originated only from calf DVT and
concluded that isolated DVT do produce fatal PE. How-
ever, Gottlieb et al28 found that VDS of the calf is not
mandatory at the initial evaluation to identify patients at
risk of clinically important PE. Even in the proximal veins,
Girard et al29 found no prognostic significance for screen-
ing in patients with proven PE. These reports, however,
studied the risk of relatively early thromboembolic sequelae
alone.
To evaluate late post-thrombotic complications that
affect the rest of a patient’s quality of life, the initial distri-
bution and extent of DVT may be important.30,31 Con-
cerning distribution of DVT, our results are comparable
with previous studies. Girard et al29 found that the preva-
lence of DVT in PE patients was 60%, which was similar to
our results, but the prevalence of distal DVT in their study
was much lower than in ours. We have been trying to rule
out even small, isolated calf vein thrombi as well as proximal
vein thrombosis because a missed diagnosis directly reflects
the low sensitivity of VDS in the diagnosis of DVT, leading
to the large volume of negative VDS studies. Our present
study showed no significant difference in the proportion of
DVT between proximal and distal veins. Furthermore,
isolated calf DVT plays an important role in the develop-
ment of PE as well as in multisegment proximal DVT.
Detailed DVT detection according to PTP scores and
D-dimer assays may thus be more logical than detection of
proximal DVT in all patients with PE. Early detection of
DVT is also useful for selecting patients who require much
dictive value for different D-dimer cutoff points
Specificity (%) PPV (%) NPV (%)
14/30 (46.7) 51/68 (75.0) 14/14 (100)
0/1 (0) 15/16 (93.8) 0/0 (NA)
2/11 (18.2) 27/36 (75.0) 2/2 (100)
12/18 (66.7) 9/16 (56.3) 12/12 (100)
al probability; NA, not applicable.pre
%)
0)
0)
0)
0)longer follow-up studies.
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this could affect the results of D-dimer testing. When a
single cutoff point of 0.5 g/mL was used, 24% of the
patients (9/38) with moderate, and 44% (12/27) with low
PTP scores showed false-positive results. When a specific
D-dimer cutoff point of 2.0 g FEU/mL was selected for
low PTP patients, the number of patients with false-positive
results dropped from 44% to 22% (6/27), a 22% change. A
sensitivity and NPV of 100% for excluding DVT in this
group was still achieved. Reducing the number of false-
positive results could decrease the number of unnecessary
VDS, leading to saving both time and money. In contrast,
a specific D-dimer cutoff point of 0.7 g FEU/mL did not
improve the discrimination power in patients who had
moderate PTP scores compared with a single cutoff level of
0.5 g/mL.
Our study has a possible limitation. The NPV of the
different D-dimer values appeared equal to that of a single
D-dimer cutoff point. In addition, although a specific
D-dimer level substantially decreased the number of false-
positive results in the low PTP group, within the group of
patients with moderate PTP, a specific D-dimer level did
not improve the specificity, leading to a relatively high
percentage of false-positive results among this group of
patients. Furthermore, the utility of D-dimer assay was not
confirmed in patients with high PTP scores. This study thus
suggested that the D-dimer test may have a high NPV and
a high sensitivity in PE patients with low PTP scores but has
scarce utility within the moderate and high PTP groups.
These results potentially provide a new strategy for the
diagnosis of DVT in patients with PE, as demonstrated in
Fig 4. Patients who have a low PTP score and D-dimer level
of 2.0 need no further investigation, whereas patients
with a low PTP score and D-dimer level of2.0 undergo a
single VDS at presentation. Patients who have a moderate
PTP score and a normal D-dimer level need no further
investigation, and patients who have a moderate PTP score
with an elevated D-dimer level should undergo a single
VDS at presentation. Finally, patients with high PTP score
should undergo VDS immediately, and those with an initial
negative scan result should have a repeat VDS after 1 week
Fig 4. Diagnostic strategy for the diagnosis of deep vein throm-
bosis (DVT) in patients with pulmonary embolism (PE).because these patients have quite high prevalence of DVT.CONCLUSION
A combination of specific D-dimer levels and clinical
probability scores is most effective in patients with low PTP
scores in excluding DVT. In patients with a moderate PTP
score, the recommended cutoff point of 0.5 g/mL may
be preferable; however, in patients with high PTP, D-dimer
testing results are not useful in excluding those with lower
extremity DVT. Thus, these results show that different
D-dimer levels for patients with different PTP scores is
more useful than a single cutoff point of 0.5 g/mL in
excluding DVT in patients with confirmed PE.
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